March 28, 2023

Volume XIII, Number 87

Advertisement
Advertisement

March 28, 2023

Subscribe to Latest Legal News and Analysis

March 27, 2023

Subscribe to Latest Legal News and Analysis
Advertisement

Foods Produced from Animal Cells: What’s in a Name?

Industry and government authorities continue to debate the regulatory pathway regarding the approval framework for foods produced from animal cells, also known as cell-based foods. One of the topics yet to reach consensus is nomenclature: what do we call these new foods made by animal cell culture technology? Let’s take a closer look to see how this is playing out across the globe.

The Food and Agriculture Organization of the United Nations (FAO) has published three technical background documents for cell-based foods[1]. One of the documents focuses on “terminologies” of cell-based food[2]. Specifically, FAO reviewed different expressions and names used for cell-based foods by government authorities, academia, consumers, and industry players around the world. These names included cultured meat, cultivated meat, lab-grown meat, fake meat, cell-based meat, synthetic meat, clean meat, artificial meat, healthy meat, imitation meat, in-vitro meat, animal-free meat, slaughter-free meat, test tube meat, cruelty-free meat, etc. FAO concluded that, overall, “cell-based,” “cultivated,” and “cultured” are the three major terminologies used or preferred by consumers, industry, and the authorities, while advising that national authorities should establish clear and consistent terminologies that align with their national and language contexts to mitigate potential miscommunication related to the nature of cell-based foods.

This past October in Singapore, the Good Food Institute APAC and APAC Society for Cellular Agriculture, along with other key industry stakeholders, met and announced their alignment with the term “cultivated” as the preferred English-language descriptor for food products grown directly from animal cells[3]

In early 2020, Professor Shouwei Wang, from the Chinese Meat Food Research Center, recommended that “cultured meat” (in Chinese: 培育肉 (pei yu rou)) is the most appropriate name to describe cell-based meat[4].

In November 2022, the United States Food and Drug Administration (FDA) completed the first pre-market consultation for a cell-based chicken product, which in its announcement, referred to the term, “human food made using animal cell culture technology”[5]. FDA clarified, however, that this is not FDA’s recommendation of the appropriate common or usual name for declaring the substance in accordance with the United States Department of Agriculture (USDA), Food Safety and Inspection Service’s (FSIS) labeling requirements[6] given that FSIS is the agency that has oversight of issues associated with labeling and the common or usual name for cultured animal cell human foods that incorporate livestock or poultry cells. Thus, FSIS’s recommendations and guidance in terms of nomenclature of cell-based foods remain to be seen[7].

We are still at the early stage of cell-based food technologies and now is the time to ask ourselves: what’s in a name? The answer will have far-reaching implications and will help educate consumers to better understand the nature of these new foods. One example in this regard is the term, “genetically modified food” (in Chinese: “zhuan ji yin shi pin”) used in China. Many consumers in China attach a negative connotation to the term “genetically modified food,” and some even interpret “genetically modified” as having an impact or potentially altering our genetic makeup after consuming the food. Undoubtedly, nomenclature, along with proper public education, can have a more positive impact on consumer perception and purchasing decisions. Since countries have not yet developed rules for nomenclature regarding this new form of alternative protein technology, now is the time to give careful consideration and thought to how this new technology is characterized because whatever name is attached to these foods will have, for good or bad, a lasting impact on consumer perception. Industry should closely monitor developments at the international, regional, and national levels and advocate collectively, with careful thought, whenever the opportunity arises.


FOOTNOTES

[1] These documents discuss “generic production processes,” “terminologies,” and “regulatory frameworks” of cell-based foods. Please see https://www.fao.org/food-safety/scientific-advice/crosscutting-and-emerging-issues/cell-based-food/en/.

[2] https://www.fao.org/documents/card/en/c/cc2241en.

[3] https://www.apac-sca.org/post/leading-apac-cellular-agriculture-stakeholders-announce-historic-agreement-in-singapore.

[4] WANG Shouwei, LI Shilei, LI Yingying, et al. Classification of artificial meat and suggestions on normalization of nomenclature for related terms[J]. Food Science, 2020, 41(11): 310-316. (in Chinese with English abstract) DOI:10.7506/spkx1002-6630-20200331-443 http://www.spkx.net.cn.

[5] https://www.fda.gov/news-events/press-announcements/fda-spurs-innovation-human-food-animal-cell-culture-technology.

[6] https://www.fda.gov/media/163260/download.

[7] Notably, on September 3, 2021, FSIS published an advanced notice of public rulemaking (ANPR) to solicit comments and information regarding the labeling of cell-cultured meat and poultry products. Please see https://www.dailyintakeblog.com/2021/09/anpr-on-labeling-cell-cultured-products-published/.

© 2023 Keller and Heckman LLPNational Law Review, Volume XIII, Number 5
Advertisement
Advertisement
Advertisement

About this Author

David J. Ettinger, Keller Heckman, Partner, Food and Drug Corporation, International Trade Lawyer, Attorney, Shanghai, China
Partner

David Ettinger joined Keller and Heckman in 1999. Mr. Ettinger represents domestic and foreign corporations in the area of food and drug law.

Mr. Ettinger relocated to Keller and Heckman's Shanghai office in November 2012 to focus on the Asian market and counsel companies in the Far East on food, drug, and chemical regulatory matters. He has extensive experience counseling clients on product development and product protection of food and drug packaging in the United States, Europe, Asia, Canada, and South America. From 2006-2007, Mr. Ettinger...

86 21-6335-1000
Jenny Li, Keller Heckman, China Food, Drug Regulation, Shanghai, International Trade
Legal Consultant

Jenny Li joined Keller and Heckman in October 2007.

Ms. Li counsels clients on regulatory issues focusing on food and drug, with an emphasis on regulatory regimes in the Asia-Pacific region. She also counsels clients on food labeling, food claims, food additives, as well as, important issues regarding food imports in Asian countries.

86-21-6335-1000